NCT02983006 Study of DS-8273a With Nivolumab in Unresectable Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1
NCT02980341 Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT02975700 A Study of PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma Status COMPLETED Phase NA
NCT02964949 Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes Status COMPLETED Phase NA
NCT02952599 Edoxaban Treatment in Routine Clinical Practice in Patients With Venous Thromboembolism in Korea and Taiwan (ETNA-VTE-KOR-TWN) Status COMPLETED Phase N/A
NCT02951039 Edoxaban Treatment in Routine Clinical Practice for Patients With Atrial Fibrillation in Korea and Taiwan (ETNA-AF-KOR-TWN) Status COMPLETED Phase N/A
NCT02948088 Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project Status COMPLETED Phase N/A
NCT02944019 Edoxaban Treatment in Routine Clinical Practice for Patients With Non Valvular Atrial Fibrillation Status COMPLETED Phase N/A
NCT02943785 Edoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF) Status COMPLETED Phase PHASE3
NCT02923115 Study to Assess the Safety, Pharmacokinetics/Dynamics of DS-1040b in Subjects With Acute Submassive Pulmonary Embolism Status COMPLETED Phase PHASE1/PHASE2
NCT02798471 Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE) Status COMPLETED Phase PHASE3
NCT02790684 A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02790671 A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02690350 An Open Study Assessing the Safety and Tolerability of U3-1784 Status TERMINATED Phase PHASE1
NCT02673866 Study to Evaluate the Efficacy and Safety of DS-1971a for the Treatment of Diabetic Peripheral Neuropathic Pain (DPNP) Status WITHDRAWN Phase PHASE2
NCT02668653 Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE3
NCT02667483 Study of DS-5141b in Patients With Duchenne Muscular Dystrophy Status COMPLETED Phase PHASE1/PHASE2